PDL BioPharma, Inc. Increase (Decrease) in Restricted Cash
PDL BioPharma, Inc. reported Increase (Decrease) in Restricted Cash of $0 for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-03.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-08-03
- PDL BioPharma, Inc. increase (decrease) in restricted cash for the quarter ending 2009-12-31 was $0.00.
- PDL BioPharma, Inc. increase (decrease) in restricted cash for the quarter ending 2009-09-30 was $0.00.
- PDL BioPharma, Inc. increase (decrease) in restricted cash for fiscal 2009 was -$3.47M.
- PDL BioPharma, Inc. increase (decrease) in restricted cash for fiscal 2008 was -$24.80M.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | |||
| 2016-06-30 | $105.94M 10-Q · filed 2017-08-03 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | |||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | -$3.47M 10-K · filed 2012-02-23 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-09 | -$3.47M 10-Q · filed 2010-11-09 | ||
| 2009-06-30 | -$3.47M 10-Q · filed 2010-07-29 | |||
| 2008-12-31 | -$24.80M 10-K · filed 2011-03-01 |